NCT06141681

Brief Summary

The objective of this observational study is to explore microcirculation in healthy volunteers and in ventilated patients in the operating room and in critical care. The general objective of this study is to evaluate microcirculation with photoplethysmography (PPG) in different pathophysiological situations and to compare PPG with available standard methods. Specifically, evaluate the correlation between the determinations of AC-DC waves obtained by Photoplethysmography (PPG) and those obtained in different dynamic tests in healthy volunteers. To compare microcirculation assessments \[capillary refill time (CRT), perfusion index (PI), perfusion index variability (PIV)\] with measurements obtained by PPG in the context of critically ill patients. To compare microcirculation assessments (CRT, PI PVI) with measurements obtained by PPG in the context of patients on invasive mechanical ventilation (IMV) in the operating room and in critical care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 19, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 10, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 21, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

November 24, 2023

Status Verified

November 1, 2023

Enrollment Period

2 years

First QC Date

November 10, 2023

Last Update Submit

November 21, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • variations in AC signal of photoplethysmography

    Changes in the AC wave of photoplethysmography (it does not currently have standardized measurement units) will be evaluated in each functional test (CRT, LPR, venous occlusion test, progressive arterial occlusion test). It will be treated as a continuous numerical variable.

    Through study completion, an average of 1 year

  • variations in DC signal of photoplethysmography

    Changes in the DC wave of photoplethysmography (it does not currently have standardized measurement units) will be evaluated in each functional test (CRT, LPR, venous occlusion test, progressive arterial occlusion test). It will be treated as a continuous numerical variable.

    Through study completion, an average of 1 year

Study Arms (3)

Healthy volunteers

\>18 years old healthy

Other: photoplethysmography

Patients in critical care unit

patient in ICU with requirement for hemodynamic monitoring

Other: photoplethysmography

Patients with ventilatory support in the operating room or critical care unit

patient in the ICU or operating room with a requirement for hemodynamic monitoring and ventilatory support

Other: photoplethysmography

Interventions

Photoplethysmography (BluePoint, Frankfurt, Germany) is the pulse wave measured by a pulse oximeter. It is obtained based on the absorbance of red/infrared light in a given tissue. The signal is made up of two components: 1) the alternating component (AC), which is the pulse wave itself, which is determined by the absorbance of pulsatile arterial blood. 2) The continuous component (DC), which represents the absorbance of venous blood and the rest of the tissues. Within these tests the investigators find vascular occlusion, elevation of the legs, raising or lowering the tested hand above/below the phlebostatic level, cold/heat test, etc. Each of them evaluates different aspects of circulation such as endothelial function, myogenic response to blood flow, perfusion pressure, autonomic reflexes, preload-dependence, or venous flow among other aspects of microcirculation.

Healthy volunteersPatients in critical care unitPatients with ventilatory support in the operating room or critical care unit

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

healthy volunteers or operating room or intensive care patients- See inclusion and exclusion criteria

You may qualify if:

  • Written informed consent.
  • Age \> 18 years.

You may not qualify if:

  • Pregnancy.
  • Smokers.
  • Respiratory and/or cardiovascular pathologies.
  • Peripheral vascular disease.
  • Operation room or Critical care Unit patients
  • Written informed consent.
  • Age \> 18 years.
  • Critical patients ventilated in the ICU of any origin.
  • Known peripheral vascular disease.
  • Burns on both upper limbs.
  • Trauma to both upper limbs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Privado de Comunidad

Mar del Plata, Buenos Aires, 7600, Argentina

RECRUITING

Study Officials

  • Nora Fuentes, PhD

    Hospital Privado de Comunidad

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gerarado Tusman, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 10, 2023

First Posted

November 21, 2023

Study Start

June 19, 2023

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

November 24, 2023

Record last verified: 2023-11

Locations